ArticleInternational urogynecology journal2026
Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisTo evaluate in-hospital analgesic use patterns for pelvic organ prolapse (POP) repair and identify predictors of higher opioid prescribing using a large, national patient administrative database.
methodsThis retrospective cohort study used a large, national administrative database (2010-2022) to identify women undergoing vaginal non-apical (NAR), vaginal apical (VAR), laparoscopic apical (LAR), or robotic apical (RAR) repairs. Opioid doses were converted to morphine milligram equivalents (MME). The primary outcome was total opioid, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAID) use. Secondary outcomes included differences in analgesic doses by surgical approach, predictors of higher POD-0 opioid use, postoperative 30-day readmission/emergency room (ER) visit rate, and the relationship between opioid use and 30-day readmission/ER visits.
resultsAmong 102,329 procedures, median POD-0 opioid dose was lowest in NAR (77.5 MME) (p < 0.001). NSAID and acetaminophen use was more common with minimally invasive approaches. Concurrent hysterectomy was the strongest predictor of higher POD-0 opioid use (exp(β) = 1.41, p < 0.001), along with adhesiolysis (exp(β) = 1.26, p < 0.001), bladder injury repair (exp(β) = 1.24, p < 0.001), anti-incontinence procedures (exp(β) = 1.05, p < 0.001), noncommercial insurance (exp(β) = 1.04, p = 0.002), and large hospital size (exp(β) = 1.09, p = 0.037). Older age (exp(β) = 0.87 per decade, p < 0.001), high Elixhauser comorbidity index (exp(β) = 0.9, p < 0.001), and NAR (exp(β) = 0.93, p < 0.001) were associated with lower opioid use. Receiving > 90 MME on POD-0 was linked to higher 30-day readmission/ER visit rates (8.3% vs 5.6%; p < 0.001, respectively).
conclusionsApical repair techniques did not show significant differences in predicting higher opioid use. Concurrent hysterectomy was the strongest predictor of higher opioid use. Higher opioid doses on POD-0 were associated with increased 30-day readmission/ER rates.
Indexed as
Identifiers
41359048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.